Bridge Therapeutics
Birmingham, US · Founded 2016
Biotech
Founders & leadership
JS
Joseph S MullinDirector
DH
David H BergstromDirector
EG
Elizabeth G KelleyDirector
TG
Tim G PearaExecutive Officer
JG
James G SullivanExecutive Officer, Director
DH
Diana H HarshbargerDirector
KS
Kelley S AltonExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements$321KraisedDec 2023 · 22 investors · Pharmaceuticals
Rule 506(c)$2MraisedApr 2019 · 11 investors · Pharmaceuticals
Rule 506(c)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.